INVIOU
INVIOU is a financial records and charges registry based on distributed ledger technology (Hyperledger Fabric). It is disrupting the SME financing industry by enabling financial institutions to provide instant, competitive safe and simple receivables financing to SMEs. Using INVIOU’s registry to verify invoice ownership and availability for financing, it greatly diminishes the costs associated with the fraud and friction which results from faulty, inflated, fictitious and double invoicing.
INVIOU
Social Links:
Industry:
Blockchain Financial Services FinTech Information Technology
Founded:
2018-01-01
Address:
Tel Aviv, Tel Aviv, Israel
Country:
Israel
Website Url:
http://www.inviou.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
970 K USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Content Delivery Network Domain Not Resolving Google Apps For Business GoDaddy DNS GStatic Google Static Content
Similar Organizations
INDODAX
INDODAX is the largest digital asset exchange in Indonesia, previously known as Bitcoin.co.id (Bitcoin Indonesia)
BitRussia
Blockchain based digital investment platform. Fully legal.
Constellation Digital Partners
Constellation Digital Partners is a Digital Financial Services Platform.
OKEx
OKEx is a digital asset exchange that provides advanced financial services to traders globally by using blockchain technology.
Current Advisors List
Current Employees Featured
Founder
Investors List
Techstars
Techstars investment in Pre Seed Round - INVIOU
Nielsen Innovate
Nielsen Innovate investment in Pre Seed Round - INVIOU
Techstars
Techstars investment in Pre Seed Round - INVIOU
Barclays Accelerator, Powered by Techstars - Tel Aviv
Barclays Accelerator, Powered by Techstars - Tel Aviv investment in Pre Seed Round - INVIOU
Official Site Inspections
http://www.inviou.com Semrush global rank: 9.53 M Semrush visits lastest month: 141
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.171
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "INVIOU"
invIOs – innovative Immune Oncology
InvIOs is developing NEXT-GENERATION CANCER THERAPEUTICS that empower and educate the immune system to fight cancer.. We leverage our … See details»
invIOs - Crunchbase Company Profile & Funding
Organization. invIOs . Connect to CRM . Save . Summary. Financials. People. … See details»
invIOs INNOVATIVE IMMUNO-ONCOLOGY - LinkedIn
InvIOs is a private biotech company focusing on discovery and development of novel cancer therapeutics that empower and educate the immune system to fight cancer. We leverage our … See details»
Press Release Distribution and Management - GlobeNewswire
VIENNA, Austria, Dec. 21, 2023 (GLOBE NEWSWIRE) -- invIOs GmbH (“invIOs”), a privately held biotechnology company developing novel therapies for cancer, will be participating in JP … See details»
INVIOU Company Profile - Office Locations, Competitors, Revenue …
INVIOU has 5 employees at their 1 location and $850 k in total funding,. See insights on INVIOU including office locations, competitors, revenue, financials, executives, subsidiaries and more … See details»
INVioU - Products, Competitors, Financials, Employees, …
INVioU is a blockchain-based platform designed to optimize conventional invoice and credit finance management, enabling minimal-risk streamlined collections and fully automated loan … See details»
ABOUT US – invIOs
InvIOs is a PRIVATE BIOTECH COMPANY focusing on discovering and developing next-generation cancer therapeutics.. We are pioneers in R&D of drug candidates targeting novel … See details»
invIOs goes live with unique cell therapy platform and clinical …
Dec 16, 2021 invIOs is a privately held biotech company based in Vienna, Austria, focused on the discovery and development of innovative cancer immunotherapies. The proprietary cell … See details»
INVIOU - Crunchbase Company Profile & Funding
INVIOU is a financial records and charges registry based on distributed ledger technology (Hyperledger Fabric). It is disrupting the SME financing industry by enabling financial … See details»
invIOs INNOVATIVE IMMUNO-ONCOLOGY - SignalHire
Organization Website: invios.com : Phone Number +43 1 86565 77: invIOs INNOVATIVE IM... industries Biotech: Headquarters Location: Campus-Vienna-Biocenter 5, 1030 AT Campus … See details»
invIOs INNOVATIVE IMMUNO-ONCOLOGY - Company Profile
Invios innovative immuno-oncology invIOs is a private biotech company focusing on discovery and development of novel cancer therapeutics that empower and educate the immune system to … See details»
invIOs raises €8.2 million in a Series A to finance pipeline progress ...
Oct 15, 2024 invIOs GmbH. Funding secures ongoing pipeline progress and achievement of preclinical and clinical milestones. Oral small molecule INV501: collaboration with Dana … See details»
invIOs - VentureRadar
Similar Companies: Immodulon Therapeutics United Kingdom n/a Immodulon is a privately-owned immuno-oncology company primarily focused on the development of novel, safe, effective and … See details»
PIPELINE – invIOs
InvIOs is advancing a focused PIPELINE OF PROGRAMS encompassing small-molecule and cell-therapy approaches. Our focus is on earlier-stage development, with a sweet spot in … See details»
invIOs INNOVATIVE IMMUNO-ONCOLOGY Company Overview, …
Oct 15, 2024 invIOs is a private biotech company focusing on discovery and development of novel cancer therapeutics that empower and educate the immune system to fight cancer. We … See details»
INVIOU's Leadership Team - Team members and org chart - The Org
About. The leadership team at INVIOU has a wealth of experience in both the corporate and startup worlds. They have held positions at large companies like NICE Systems and shlomo … See details»
Press Release: invIOs raises €8.2 million in a Series A to finance ...
Vienna, Austria, 15 October 2024: invIOs GmbH (“invIOs”), a privately held biotechnology company developing novel therapies for cancer, today announced that the company has … See details»
invIOs goes live with unique cell therapy platform and clinical …
VIENNA, Austria, Dec. 16, 2021 (GLOBE NEWSWIRE) -- invIOs (innovative Immuno-Oncology) GmbH, a privately held biotechnology company developing novel therapies for cancer, is … See details»
INVioU | StartupHub.ai
Jan 1, 2018 Description: INVioU is a blockchain-based platform designed to optimize invoice and credit finance management, enabling minimal-risk streamlined collections, and fully … See details»
CAREER – invIOs
Working at invIOs gives you the opportunity to contribute to solving some of the toughest challenges in treating cancer. And while working in Life Sciences can be challenging, we … See details»